AKT1 and neoplasm: TRIM31 has been proposed to be involved in several carcinogenic mechanisms, such as regulating the P53, mTORC1, PI3K-Akt, NF-kappa B and Wnt/β-catenin pathways to promote tumor onset and progression (23).